MapLight Therapeutics (MPLT) CFO sells 2,922 shares mainly for tax withholding

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

MapLight Therapeutics Chief Financial Officer Vishwas Setia reported open-market sales of Voting Common Stock primarily to cover taxes on restricted stock unit vesting. Across three transactions on April 15–16, he sold a total of 2,922 shares at weighted average prices around $26.87–$27.49. The sales included shares required to satisfy statutory tax withholding obligations. After these transactions, he directly owned 392,627 shares of Voting Common Stock, indicating he retained the vast majority of his equity position.

Insider Trade Summary

Net Seller: 2,922 shares ($78,572)

Net Sell 3 txns

Insider Setia Vishwas

Role Chief Financial Officer

Sold 2,922 shs ($79K)

Type	Security	Shares	Price	Value
Sale	Voting Common Stock	29	$27.01	$783.29
Sale	Voting Common Stock	87	$27.49	$2K
Sale	Voting Common Stock	2,806	$26.87	$75K

Holdings After Transaction: Voting Common Stock — 392,714 shares (Direct)

Footnotes (1)

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive.

Key Figures

Total shares sold: 2,922 shares Shares sold at $26.87: 2,806 shares Shares sold at $27.01: 29 shares +5 more

8 metrics

Total shares sold 2,922 shares Net open-market sales reported on April 15–16

Shares sold at $26.87 2,806 shares Open-market sale of Voting Common Stock on April 15

Shares sold at $27.01 29 shares Open-market sale of Voting Common Stock on April 16

Shares sold at $27.49 87 shares Open-market sale of Voting Common Stock on April 16

Shares held after final sale 392,627 shares Direct ownership of Voting Common Stock following April 16 trades

Price range (footnote F2) $26.33–$27.29 Weighted average sale range for one transaction group

Price range (footnote F3) $26.2201–$27.2197 Weighted average sale range for another transaction group

Price range (footnote F4) $27.22–$27.9898 Weighted average sale range for final transaction group

Key Terms

restricted stock units, statutory tax withholding obligations, weighted average price, Voting Common Stock, +1 more

5 terms

restricted stock units financial

"in connection with the vesting of the restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

statutory tax withholding obligations financial

"shares required to be sold to cover the statutory tax withholding obligations"

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Voting Common Stock financial

"security_title": "Voting Common Stock""

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Setia Vishwas

(Last)

(First)

(Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY

CALIFORNIA

94063

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Voting Common Stock	04/15/2026		S		2,806⁽¹⁾	D	$26.87⁽²⁾	392,743	D
Voting Common Stock	04/16/2026		S		29⁽¹⁾	D	$27.01⁽³⁾	392,714	D
Voting Common Stock	04/16/2026		S		87⁽¹⁾	D	$27.49⁽⁴⁾	392,627	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive.

4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did MapLight Therapeutics (MPLT) report for Vishwas Setia?

MapLight Therapeutics reported that CFO Vishwas Setia sold 2,922 shares of Voting Common Stock in three open-market transactions. These trades occurred on April 15–16 and were primarily linked to covering statutory tax withholding obligations related to restricted stock unit vesting.

At what prices did MPLT’s CFO sell his MapLight Therapeutics shares?

The reported sales by MPLT’s CFO occurred at weighted average prices near $26.87 and between $27.01 and $27.49 per share. Footnotes note that each line represents multiple trades within stated price ranges, and detailed breakdowns are available on request from the company or regulators.

How many MapLight Therapeutics (MPLT) shares does the CFO hold after these Form 4 sales?

After the reported sales, CFO Vishwas Setia directly holds 392,627 shares of MapLight Therapeutics Voting Common Stock. This indicates that the 2,922 shares sold represent only a small fraction of his overall stake, leaving his remaining equity position largely intact.

Why did MapLight Therapeutics’ CFO sell shares according to the Form 4 footnotes?

Footnotes state that the reported share sales represent the number of shares required to be sold to cover statutory tax withholding obligations. These obligations arose in connection with the vesting of restricted stock units, making the transactions primarily tax-related rather than discretionary portfolio changes.

Were the MapLight Therapeutics (MPLT) insider sales single trades or multiple transactions?

Each reported line reflects weighted average prices for multiple underlying trades within specific price ranges. Footnotes explain that shares were sold in numerous transactions, and the CFO undertakes to provide detailed per-trade information upon request to the company, shareholders, or SEC staff.